Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARMUSTINE for B-cell type acute leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where CARMUSTINE was used for B-cell type acute leukaemia.

Most Reported Side Effects for CARMUSTINE

Side Effect Reports % Deaths Hosp.
Off label use 454 13.5% 109 154
Febrile neutropenia 297 8.8% 44 97
Myelodysplastic syndrome 295 8.7% 153 41
Disease progression 241 7.1% 34 32
Acute myeloid leukaemia 180 5.3% 134 43
Thrombocytopenia 174 5.2% 34 32
Pyrexia 152 4.5% 36 76
Drug ineffective 149 4.4% 23 47
Mucosal inflammation 148 4.4% 17 40
Second primary malignancy 141 4.2% 82 52
Infection 139 4.1% 77 37
Diarrhoea 138 4.1% 27 52
Product use in unapproved indication 136 4.0% 47 55
Neutropenia 127 3.8% 42 40
Haematotoxicity 110 3.3% 3 0

Other Indications for CARMUSTINE

Diffuse large b-cell lymphoma (551) Bone marrow conditioning regimen (431) Non-hodgkin's lymphoma (222) Hodgkin's disease (206) Product used for unknown indication (204) Mantle cell lymphoma (183) Plasma cell myeloma (137) Central nervous system lymphoma (136) B-cell lymphoma (128) Lymphoma (128)

Other Drugs Used for B-cell type acute leukaemia

METHOTREXATE (925) VINCRISTINE (889) BLINATUMOMAB (622) DEXAMETHASONE (606) CYCLOPHOSPHAMIDE (586) CYTARABINE (582) PEGASPARGASE (374) DOXORUBICIN (360) TISAGENLECLEUCEL (354) MERCAPTOPURINE (308)

Related Pages

CARMUSTINE Full Profile All B-cell type acute leukaemia Drugs CARMUSTINE Demographics CARMUSTINE Timeline